Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…
Read More
FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine
The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance on Moderna’s innovative mRNA influenza vaccine candidate,…
Read More
Amid vaccine policy whiplash, here’s how a pediatrician talks to families
The enduring mission of Science News, established nearly a century ago, remains steadfast: to empower individuals with the knowledge and…
Read More
FDA Refuses to Review Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Design
Washington D.C. – Moderna, a leading biotechnology company, has announced that the U.S. Food and Drug Administration (FDA) has issued…
Read More
FDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine
In a significant development for vaccine innovation and public health, the U.S. Food and Drug Administration (FDA) has reversed its…
Read More
The modification of lipid nanoparticles with aromatic rings and disulfide bonds enhances mRNA vaccine delivery.
Researchers at the University of Pennsylvania (PA, USA) have achieved a significant breakthrough in mRNA vaccine technology, modifying lipid nanoparticles…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin Discusses Screwworm, Shingles Vaccine’s Anti-Aging Effects, and Current Public Health Data
In a recent clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive…
Read More
FDA refuses to review Moderna’s mRNA flu vaccine
Moderna, a leading biotechnology company known for its pioneering work in mRNA technology, has been dealt a significant setback by…
Read More
FDA reverses course, agrees to review Moderna’s mRNA flu vaccine
The U.S. Food and Drug Administration (FDA) has officially reversed its earlier stance, agreeing to review Moderna’s messenger RNA (mRNA)…
Read More
Meningitis B Vaccine Expansion Under Consideration Amidst Kent Outbreak
The United Kingdom’s Health Secretary, Wes Streeting, is reportedly considering expanding the national immunisation schedule to include the Meningitis B…
Read MoreYOU MAY HAVE MISSED
